Source-grounded facts extracted from ESTABLISHMENT LABS HOLDINGS INC.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
ESTABLISHMENT LABS HOLDINGS INC. reported the first quarter ended March 31, 2026 results: revenue $59.9 million, net income $13.4 million. Guidance raised.
“breast aesthetics and reconstruction, today announced financial results for the first quarter ended March 31, 2026. First Quarter Highlights and Outlook (Unaudited) • Revenue of $59.9 million, up 44.7% from Q1 2025, with guidance raised to $266.5 million to $268.5 million • $19.6 million of Motiva sales in the United States, up 13.3% from Q4 2025 • Minimally invasive”
Debt Financings
ESTABLISHMENT LABS HOLDINGS INC. incurred term loan of an aggregate principal amount of up to $300,000,000 with Oaktree Fund Administration, LLC (as administrative agent) and the Lenders at 8.75% per annum maturing April 30, 2031.
“On April 30, 2026 (the “Closing Date”), Establishment Labs Holdings Inc. (the “Company”) entered into an Amended Credit Agreement and Guaranty (the “Credit Agreement”) together with certain of its subsidiaries party thereto as guarantors, the lenders from time to time party thereto (the “Lenders”), and Oaktree Fund Administration, LLC, as administrative agent for the Lenders (in such capacity, the “Administrative Agent”), pursuant to which the Lenders agreed to make term loans to the Company in an aggregate principal amount of up to $300,000,000 (the “Term Loans”). The Credit Agreement amended and restated that certain Credit Agreement and Guaranty dated as of April, 26 2022 (as amended from time to time) (the “Prior Credit Agreement”), by and among the Company, its subsidiaries party thereto as guarantors, the lenders party thereto and Oaktree Fund Administration, LLC, as administrative agent. The proceeds of the Term Loans will be used for (a) repayment of outstanding indebtedness un”
Material Agreements
ESTABLISHMENT LABS HOLDINGS INC. amended Amended Credit Agreement and Guaranty with Oaktree Fund Administration, LLC valued at $300,000,000 term loans (effective 2026-04-30).
“On April 30, 2026 (the “Closing Date”), Establishment Labs Holdings Inc. (the “Company”) entered into an Amended Credit Agreement and Guaranty (the “Credit Agreement”) together with certain of its subsidiaries party thereto as guarantors, the lenders from time to time party thereto (the “Lenders”), and Oaktree Fund Administration, LLC, as administrative agent for the Lenders (in such capacity, the “Administrative Agent”), pursuant to which the Lenders agreed to make term loans to the Company in an aggregate principal amount of up to $300,000,000 (the “Term Loans”).”
Debt Financings
ESTABLISHMENT LABS HOLDINGS INC. incurred term loan of $25,000,000 with Oaktree Fund Administration, LLC.
“On September 29, 2025, the Company fully borrowed the Tranche D Term Loans available under the Agreement in an amount equal to $25,000,000.”
Fillipo "Peter" Caldini was appointed as Class II Director at ESTABLISHMENT LABS HOLDINGS INC..
“The Board also appointed Mr. Caldini as a Class II director of the Company, effective May 24, 2025.”
Fillipo "Peter" Caldini was appointed as Chief Executive Officer at ESTABLISHMENT LABS HOLDINGS INC..
“appointed the Company’s interim Chief Executive Officer Fillipo “Peter” Caldini to serve as Chief Executive Officer, effective May 7, 2025.”
Fillipo "Peter" Caldini was appointed as Interim CEO at ESTABLISHMENT LABS HOLDINGS INC..
“Fillipo “Peter” Caldini, the Company’s current President, will serve as Interim CEO as of March 1, 2025.”
Juan José Chacón-Quirós retired as Chief Executive Officer at ESTABLISHMENT LABS HOLDINGS INC..
“Juan José Chacón-Quirós, the Company’s Chief Executive Officer, has provided notice of his decision to retire from his position as Chief Executive Officer, effective on March 1, 2025.”
Fillipo "Peter" Caldini was appointed as President at ESTABLISHMENT LABS HOLDINGS INC..
“On August 20, 2024, the Board of Directors of Establishment Labs Holdings Inc. (the “Company”) appointed Fillipo “Peter” Caldini to the position of President of the Company effective immediately (the “Start Date”).”
Earnings Releases
ESTABLISHMENT LABS HOLDINGS INC. reported the three months ended March 31, 2024 results: revenue $37.2 million, net income $16.2 million. Guidance reaffirmed.
“and reconstruction, today announced financial results for the first quarter ended March 31, 2024. First Quarter Highlights and Outlook • First quarter worldwide revenue of $37.2 million. • 2024 revenue guidance remains $174 million to $184 million, an increase of 5% to 11% over 2023. Guidance does not include revenue from Motiva Implants ® in the United States,”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.